G'day Bas, good to see you are still doing the work of the old Democrats (Keeping them honest).
Since selling out before the interminable suspension, I've been revisiting CGB from time to time, and my main take on their strategy is that they seem far more intent on adding new (unprofitable) divisions and activities to the company, rather than focusing on doing one thing well and doing it profitably.
History tells us that this sort of strategy is the long winding road to ultimate oblivion.
A flurry of activity might impress and keep the interest of some investors and potential investors, but what serious investors are really interested in is the bottom line, and some consistent profits.
With the developing world-wide oversupply of hemp and medicinal cannabis products, which is likely to grow exponentially worse in 2020, careful and prudent management of capital and avoiding over-reach should be guiding principles for all companies in these sectors.
Cheers,
Mike
CGB Price at posting:
2.5¢ Sentiment: None Disclosure: Not Held
